Brief: Serina Therapeutics Receives Second $5 Mln Tranche To Strengthen Cash Position
03/02/2025 22:31
Feb 3 (Reuters) - Serina Therapeutics Inc SER.A :
* SERINA THERAPEUTICS RECEIVES SECOND $5 MILLION TRANCHE TO
STRENGTHEN CASH POSITION AHEAD OF PHASE 1 CLINICAL TRIAL IN
ADVANCED PARKINSON'S DISEASE PATIENTS
* SERINA THERAPEUTICS INC - FUNDING TO ADVANCE SER-252 INTO
PHASE
1 TRIAL IN H2 2025
Source text: ID:nGNX4tg92z
Further company coverage: SER.A
((reuters.briefs@thomsonreuters.com;))
Recent news on Serina Therapeutics
See all newsBrief: Serina Therapeutics Inc Reports Cohort 1 Observations From Ser-252 Registrational Study In Advanced Parkinson’S Disease And Advances To Cohort 2
Brief: Serina Therapeutics - Offers Up To 12,500,000 Shares Of Common Stock By Roth Principal Investments - SEC Filing
Serina Therapeutics Q2 net loss widens on higher expenses
Brief: Serina Therapeutics Appoints Farrell Simon To Its Board Of Directors
Brief: Serina Therapeutics Completes Sentinel Dosing In Cohort 1 Of Phase 1B Registrational Trial Of SER-252